GRDN
Guardian Pharmacy Services, Inc.
NYSEUSDEQUITY
Healthcare
DELAYED
Buy
+33/100
Last price
41.12
▼ 0.11 (0.28%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
41.20
Prev close
41.23
Day high
41.52
Day low
41.12
Volume
3.74K
Market cap
$2.60B
P/E (TTM)
39.92
52W range
23.14 – 48.33
Day trading desk
Gap from prior close
-0.00%
Prior close 41.20
VWAP
—
—
Relative volume
0.00×
Quiet session
Session range
1.06%
41.12 – 41.55
Position in range
0%
Near session low
ATR (14D)
1.44
3.51% of price
Prior day high
42.95
PDH
Prior day low
40.80
PDL
Bid / ask spread
—
Quote not published
Session volume
—
Avg 473.34K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+0.82%
-0.9%
1M
-3.14%
-4.4%
3M
+0.13%
-3.1%
6M
+2.71%
-12.1%
YTD
+36.64%
+22.9%
1Y
+73.12%
+57.6%
3Y
—
-81.6%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on GRDN open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
36.39M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 25, 26 | BINDLEY WILLIAM E Director and Beneficial Owner of more than 10% of a Class of Security |
— | 6.10M | — | Indirect |
| Sep 25, 26 | BURKE FRED Chief Executive Officer |
— | 1.30M | — | Direct |
| Sep 25, 26 | ACKERMAN JOHN Director and Beneficial Owner of more than 10% of a Class of Security |
— | 1.88M | — | Indirect |
| Sep 25, 26 | MORRIS DAVID K Chief Operating Officer |
— | 641.87K | — | Direct |
| Sep 25, 26 | FORBES KENDALL Beneficial Owner of more than 10% of a Class of Security |
— | 608.57K | — | Direct |
| Sep 25, 26 | SALENTINE THOMAS J. JR. Director and Beneficial Owner of more than 10% of a Class of Security |
— | 6.10M | — | Indirect |
| Sep 25, 26 | BINDLEY CAPITAL PARTNERS I, L.L.C Beneficial Owner of more than 10% of a Class of Security |
— | 6.10M | — | Direct |
| Sep 25, 26 | PHARMACY INVESTORS, LLC Beneficial Owner of more than 10% of a Class of Security |
— | 1.41M | — | Direct |
| Sep 25, 26 | CARDINAL EQUITY FUND L P Beneficial Owner of more than 10% of a Class of Security |
— | 471.06K | — | Direct |
| Sep 25, 26 | EAKINS RICHARD Officer |
— | 36.05K | — | Direct |
| Sep 25, 26 | WEIR ROBERT Officer |
— | 23.45K | — | Direct |
| Sep 25, 26 | TOWNS DOUGLAS General Counsel |
— | 23.45K | — | Direct |
| Sep 25, 26 | TUCH JEFFREY Officer |
— | 55.58K | — | Direct |
| Sep 25, 26 | MARTIN DAVID NORMAN Officer |
— | 39.87K | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ACKERMAN JOHN |
Director and Beneficial Owner of more than 10% of a Class of Security | — | Conversion of Exercise of derivative security |
BINDLEY CAPITAL PARTNERS I, L.L.C |
Beneficial Owner of more than 10% of a Class of Security | 16.67M | Conversion of Exercise of derivative security |
BINDLEY WILLIAM E |
Director and Beneficial Owner of more than 10% of a Class of Security | — | Conversion of Exercise of derivative security |
BURKE FRED |
Chief Executive Officer | 3.44M | Conversion of Exercise of derivative security |
CARDINAL EQUITY FUND L P |
Beneficial Owner of more than 10% of a Class of Security | 1.29M | Conversion of Exercise of derivative security |
FORBES KENDALL |
Beneficial Owner of more than 10% of a Class of Security | 1.65M | Conversion of Exercise of derivative security |
MORRIS DAVID K |
Chief Operating Officer | 896.34K | Conversion of Exercise of derivative security |
PHARMACY INVESTORS, LLC |
Beneficial Owner of more than 10% of a Class of Security | 3.86M | Conversion of Exercise of derivative security |
SALENTINE THOMAS J. JR. |
Director and Beneficial Owner of more than 10% of a Class of Security | — | Conversion of Exercise of derivative security |
TUCH JEFFREY |
Officer | 231.85K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$2.60B
Enterprise value$2.57B
Revenue (TTM)$1.46B
Gross profit$316.58M
EBITDA$109.41M
Net income$65.91M
EPS (TTM)$1.03
Free cash flow$64.55M
Total cash$89.81M
Total debt$39.27M
Book value / share$3.88
Shares outstanding63.32M
Float22.38M
Short % of float6.54%
Dividend yield0.00%
Beta (5Y)0.02
Valuation & profitability ratios
Trailing P/E39.92
Forward P/E28.67
PEG ratio—
Price / sales—
Price / book10.60
EV / revenue1.76
EV / EBITDA23.50
Gross margin21.63%
Operating margin3.48%
Profit margin4.50%
Return on equity30.42%
Return on assets13.45%
Debt / equity15.24
Current ratio1.65
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.45B | $1.23B | $1.05B | $908.91M | +17.9% |
| Operating revenue | $1.45B | $1.23B | $1.05B | $908.91M | +17.9% |
| Cost of revenue | $1.16B | $984.04M | $837.88M | $723.04M | +17.5% |
| Gross profit | $292.72M | $244.37M | $208.31M | $185.87M | +19.8% |
| Selling, general & admin | $220.02M | $307.29M | $167.36M | $133.88M | -28.4% |
| Total operating expense | $220.02M | $307.29M | $167.36M | $133.88M | -28.4% |
| Operating income | $72.70M | -$62.92M | $40.95M | $51.99M | +215.5% |
| Net interest income | -$665.00K | -$3.28M | -$2.86M | -$1.93M | +79.7% |
| Pre-tax income | $73.42M | -$66.48M | $37.72M | $49.66M | +210.4% |
| Tax provision | $24.46M | $4.56M | $0 | — | +437.0% |
| Net income | $49.22M | -$87.29M | $23.90M | $35.42M | +156.4% |
| Net income to common | $49.22M | -$110.05M | $0 | $35.42M | +144.7% |
| Basic EPS | 0.79 | -1.77 | 0.00 | 0.58 | +144.6% |
| Diluted EPS | 0.78 | -1.77 | 0.00 | 0.58 | +144.1% |
| EBIT | $74.09M | -$63.20M | $40.58M | $51.59M | +217.2% |
| EBITDA | $96.42M | -$43.43M | $58.81M | $68.15M | +322.0% |
| Basic shares | 62.39M | 62.01M | 60.84M | 60.84M | +0.6% |
| Diluted shares | 63.30M | 62.01M | 60.84M | 60.84M | +2.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $65.62M | $4.66M | $752.00K | $607.00K | — | +1,308.1% |
| Cash & short-term investments | $65.62M | $4.66M | $752.00K | $607.00K | — | +1,308.1% |
| Accounts receivable | $101.61M | $97.15M | $77.26M | $67.83M | — | +4.6% |
| Inventory | $43.36M | $40.55M | $36.73M | $41.44M | — | +6.9% |
| Total current assets | $221.63M | $151.99M | $129.60M | $120.00M | — | +45.8% |
| Property, plant & equipment | $90.17M | $78.96M | $73.18M | $65.19M | — | +14.2% |
| Goodwill & intangibles | $98.22M | $84.21M | $68.03M | $70.49M | — | +16.6% |
| Total assets | $412.66M | $320.81M | $271.17M | $256.11M | — | +28.6% |
| Total current liabilities | $160.70M | $144.12M | $138.01M | $112.00M | — | +11.5% |
| Current debt | — | — | $12.98M | $7.96M | $3.71M | — |
| Long-term debt | — | — | $18.99M | $22.97M | $26.99M | — |
| Total debt | $37.14M | $30.13M | $61.00M | $56.81M | — | +23.3% |
| Total liabilities | $194.73M | $170.83M | $211.31M | $180.19M | — | +14.0% |
| Retained earnings | $66.34M | $17.12M | — | — | — | +287.4% |
| Shareholder equity | $205.76M | $142.67M | $0 | $0 | — | +44.2% |
| Working capital | $60.93M | $7.86M | -$8.41M | $7.99M | — | +674.8% |
| Net tangible assets | $107.54M | $58.46M | -$68.03M | -$70.49M | — | +83.9% |
| Shares issued | 63.32M | 63.29M | 60.84M | 60.84M | — | +0.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $48.96M | -$71.03M | $37.72M | $49.66M | +168.9% |
| Depreciation & amortisation | $22.34M | $19.77M | $18.23M | $16.56M | +13.0% |
| Stock-based compensation | $13.85M | $131.49M | -$6.09M | -$3.38M | -89.5% |
| Change in working capital | $6.38M | -$29.41M | $15.60M | -$18.72M | +121.7% |
| Operating cash flow | $100.25M | $57.96M | $70.82M | $48.52M | +73.0% |
| Capital expenditure | -$19.55M | -$16.37M | -$14.56M | -$16.77M | -19.4% |
| Investing cash flow | -$32.23M | -$30.41M | -$13.44M | -$17.90M | -6.0% |
| Share buybacks | -$29.04M | -$55.18M | $0 | — | +47.4% |
| Dividends paid | $0 | -$35.75M | -$38.42M | -$30.80M | +100.0% |
| Financing cash flow | -$7.07M | -$23.64M | -$57.23M | -$45.03M | +70.1% |
| Free cash flow | $80.71M | $41.59M | $56.26M | $31.75M | +94.1% |
| End cash position | $65.62M | $4.66M | $752.00K | $607.00K | +1,308.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $351.77M | $336.60M | $397.62M | $377.43M | $344.33M | +4.5% |
| Operating revenue | $351.77M | $336.60M | $397.62M | $377.43M | $344.33M | +4.5% |
| Cost of revenue | $271.72M | $260.29M | $312.11M | $302.71M | $276.19M | +4.4% |
| Gross profit | $80.04M | $76.31M | $85.50M | $74.72M | $68.15M | +4.9% |
| Selling, general & admin | $59.40M | $58.63M | $54.74M | $58.37M | $55.57M | +1.3% |
| Total operating expense | $59.40M | $58.63M | $54.74M | $58.37M | $55.57M | +1.3% |
| Operating income | $20.64M | $17.68M | $30.76M | $16.35M | $12.58M | +16.8% |
| Net interest income | -$154.00K | -$154.00K | -$163.00K | -$160.00K | -$172.00K | 0.0% |
| Pre-tax income | $29.79M | $18.29M | $31.10M | $16.63M | $12.59M | +62.9% |
| Tax provision | $7.67M | $4.75M | $9.83M | $7.04M | $3.76M | +61.5% |
| Net income | $21.87M | $13.29M | $20.92M | $9.82M | $9.03M | +64.5% |
| Net income to common | $21.87M | $13.29M | $20.92M | $9.82M | $9.03M | +64.5% |
| Basic EPS | 0.35 | 0.21 | 0.33 | 0.16 | 0.15 | +66.7% |
| Diluted EPS | 0.34 | 0.21 | 0.33 | 0.15 | 0.14 | +61.9% |
| EBIT | $29.95M | $18.45M | $31.26M | $16.79M | $12.76M | +62.3% |
| EBITDA | $35.75M | $24.42M | $37.00M | $22.63M | $18.25M | +46.4% |
| Basic shares | 63.33M | 63.32M | 63.32M | 62.12M | 62.05M | +0.0% |
| Diluted shares | 63.84M | 63.69M | 63.62M | 63.43M | 63.20M | +0.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $89.81M | $64.89M | $65.62M | $36.49M | $18.82M | +38.4% |
| Cash & short-term investments | $89.81M | $64.89M | $65.62M | $36.49M | $18.82M | +38.4% |
| Accounts receivable | $103.77M | $111.70M | $101.61M | $106.19M | $94.13M | -7.1% |
| Inventory | $50.44M | $47.16M | $43.36M | $47.86M | $44.16M | +7.0% |
| Total current assets | $254.67M | $235.18M | $221.63M | $198.28M | $170.46M | +8.3% |
| Property, plant & equipment | $88.89M | $90.89M | $90.17M | $88.32M | $86.46M | -2.2% |
| Goodwill & intangibles | $96.36M | $97.22M | $98.22M | $98.48M | $93.75M | -0.9% |
| Total assets | $443.58M | $426.94M | $412.66M | $390.04M | $356.33M | +3.9% |
| Total current liabilities | $154.04M | $160.54M | $160.70M | $161.95M | $143.99M | -4.0% |
| Total debt | $35.24M | $36.88M | $37.14M | $34.08M | $33.70M | -4.5% |
| Total liabilities | $185.94M | $194.52M | $194.73M | $194.54M | $176.66M | -4.4% |
| Retained earnings | $101.51M | $79.64M | $66.34M | $45.42M | $35.60M | +27.5% |
| Shareholder equity | $245.61M | $220.89M | $205.76M | $183.76M | $169.56M | +11.2% |
| Working capital | $100.63M | $74.64M | $60.93M | $36.33M | $26.47M | +34.8% |
| Net tangible assets | $149.25M | $123.67M | $107.54M | $85.27M | $75.81M | +20.7% |
| Shares issued | 63.33M | 63.32M | 63.32M | 63.32M | 63.30M | +0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $22.12M | $13.54M | $21.27M | $9.59M | $8.83M | — | +63.3% |
| Depreciation & amortisation | $5.81M | $5.98M | $5.74M | $5.84M | $5.49M | — | -2.8% |
| Stock-based compensation | $2.93M | $1.86M | $1.08M | $4.36M | $4.45M | — | +57.5% |
| Change in working capital | -$2.74M | -$16.30M | $2.19M | $6.31M | -$405.00K | — | +83.2% |
| Operating cash flow | $30.02M | $6.06M | $34.60M | $28.17M | $19.94M | — | +395.3% |
| Capital expenditure | -$4.62M | -$5.02M | -$4.23M | -$5.21M | -$4.31M | — | +8.0% |
| Investing cash flow | -$4.31M | -$4.75M | -$4.71M | -$8.97M | -$13.00M | — | +9.3% |
| Share buybacks | $0 | -$30.28M | $0 | $0 | -$29.04M | — | +100.0% |
| Dividends paid | — | — | $0 | $0 | $0 | $0 | — |
| Financing cash flow | -$805.00K | -$2.04M | -$758.00K | -$1.53M | -$2.11M | — | +60.5% |
| Free cash flow | $25.41M | $1.04M | $30.37M | $22.96M | $15.63M | — | +2,336.0% |
| End cash position | $89.81M | $64.89M | $65.62M | $36.49M | $18.82M | — | +38.4% |
Options analytics
Put / call volume
1.50
Put-heavy session
Put / call open interest
0.32
Positioning, not flow
Max pain
35.00
-14.9% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
+12.5%
Puts bid over calls
Call volume
24
Contracts, this expiry
Put volume
36
Contracts, this expiry
Heaviest call OI
35.00
72 contracts
Heaviest put OI
50.00
40 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.26 | 0.29 | +10.8% |
| Mar 2026 | 0.24 | 0.29 | +20.8% |
| Dec 2025 | 0.27 | 0.37 | +38.3% |
| Sep 2025 | 0.24 | 0.25 | +6.4% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.31 | 7 | $365.76M | -3.1% |
| Next quarter | 0.41 | 7 | $387.78M | -2.5% |
| Current year | 1.30 | 7 | $1.44B | -0.5% |
| Next year | 1.43 | 7 | $1.53B | +6.4% |
Analyst targets & ownership
Mean target$49.86
High target$52.00
Low target$47.00
Implied upside21.26%
Analyst count7
ConsensusSTRONG BUY
Strong buy / Buy1 / 6
Hold0
Sell / Strong sell0 / 0
Held by insiders57.45%
Held by institutions60.70%
Institutions holding283
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
41.28
-0.41% from price
SMA 20
43.17
-4.77% from price
SMA 50
40.90
+0.53% from price
SMA 100
40.59
+1.30% from price
SMA 200
37.29
+10.26% from price
EMA 12
41.82
-1.68% from price
EMA 26
41.84
-1.72% from price
EMA 50
41.32
-0.50% from price
RSI (14)
46.2
Neutral
MACD (12,26,9)
-0.02
Hist -0.34
ATR (14)
1.44
3.51% of price
Realised vol 30D
38.0%
Annualised
Bollinger upper
47.54
20, 2σ
Bollinger lower
38.81
20, 2σ
50 / 200 cross
Golden
40.90 vs 37.29
Trend bias
Above 200
+10.26%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.62
Less volatile than market
Correlation to SPY
0.20
Largely independent
Realised vol 30D
38.0%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-15.4%
Peak to trough
Max drawdown 5Y
-27.2%
Peak to trough
ATR 14
1.44
3.51% of price
Beta (reported)
0.02
5Y monthly, from filing
Short interest
Shares short
2.43M
Prior 3.01M
Change vs prior
-19.3%
Shorts covering
% of float
6.54%
Normal
% of shares out
3.83%
Against total outstanding
Days to cover
5.1
Crowded exit
Float
22.38M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 23, 26 | Keybanc | INITIATED | — | Overweight |
| Sep 21, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Aug 7, 26 | Oppenheimer | MAINTAINED | Outperform | Outperform |
| Jun 17, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Jun 17, 26 | B of A Securities | MAINTAINED | Buy | Buy |
| May 7, 26 | Oppenheimer | MAINTAINED | Outperform | Outperform |
| Apr 27, 26 | B of A Securities | INITIATED | — | Buy |
| Apr 13, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Mar 30, 26 | Jefferies | INITIATED | — | Buy |
| Mar 12, 26 | Oppenheimer | MAINTAINED | Outperform | Outperform |
| Mar 12, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Jan 14, 26 | Stephens & Co. | MAINTAINED | Overweight | Overweight |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-10
Periodic Financial Reports
10-Q · 2026-08-06
Corporate Changes & Voting Matters
8-K · 2026-06-22
Corporate Changes & Voting Matters
8-K · 2026-05-28
Corporate Changes & Voting Matters
8-K · 2026-05-07
Offering Registrations
S-8 · 2026-05-06
Proxy Statements
DEF 14A · 2026-03-26
Corporate Changes & Voting Matters
8-K · 2026-03-23
Headlines
Zacks.com featured highlights include CNXN, ECG, GRDN, EXPD and PBF
Zacks · 8d ago
Bet on Winning DuPont Analysis & Pick 5 Top Stocks
Zacks · 9d ago
KeyBanc Initiates Guardian Pharmacy Services at Overweight With $52 Price Target
MT Newswires · 14d ago
Truist Raises Price Target on Guardian Pharmacy Services to $51 From $47, Keeps Buy Rating
MT Newswires · 16d ago
Guardian Pharmacy Services Buys Assets From Nautilus Pharmacy
MT Newswires · 36d ago
Guardian Pharmacy Services Acquires Assets of Tennessee-Based Nautilus Pharmacy
Business Wire · 36d ago
Guardian Pharmacy Services, Inc., to Participate in Upcoming Jefferies Healthcare Services Investor Conference
Business Wire · 49d ago
Guardian Pharmacy Services (GRDN) Q2 2026 Earnings Call Transcript
Motley Fool · 55d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.